Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Zainab Abdelaziz"'
Autor:
Carissa Beaulieu, Arthur Lui, Dimas Yusuf, Zainab Abdelaziz, Brock Randolph, Eugene Batuyong, Sunita Ghosh, Oliver F. Bathe, Vincent Tam, Jennifer L. Spratlin
Publikováno v:
Current Oncology, Vol 28, Iss 1, Pp 417-427 (2021)
Background: Biliary tract cancers (BTC) are uncommon malignancies and are underrepresented in the literature. Methods: We performed a retrospective population-based review of adult patients with biopsy-confirmed BTC in Alberta from 2000 to 2015. Demo
Externí odkaz:
https://doaj.org/article/0e6e1a15eea34548961566751d9d5b63
Autor:
Sunita Ghosh, Arthur Lui, Zainab Abdelaziz, Eugene Batuyong, Vincent C. Tam, Dimas Yusuf, Oliver F. Bathe, Brock Randolph, Jennifer L. Spratlin, Carissa Beaulieu
Publikováno v:
Current Oncology
Current Oncology, Vol 28, Iss 44, Pp 417-427 (2021)
Volume 28
Issue 1
Pages 44-427
Current Oncology, Vol 28, Iss 44, Pp 417-427 (2021)
Volume 28
Issue 1
Pages 44-427
Background: Biliary tract cancers (BTC) are uncommon malignancies and are underrepresented in the literature. Methods: We performed a retrospective population-based review of adult patients with biopsy-confirmed BTC in Alberta from 2000 to 2015. Demo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c99e0c0e2306a7aef291ba90eb835a7
http://europepmc.org/articles/PMC7903272
http://europepmc.org/articles/PMC7903272
Autor:
Zainab Abdelaziz, Arthur Lui, John R. Mackey, Jennifer L. Spratlin, Dimas Yusuf, Larissa J. Vos, Sunita Ghosh
Publikováno v:
JCO precision oncology. 3
Purpose Gemcitabine, the primary drug for the treatment of pancreatobiliary cancer (PBC), requires human equilibrative nucleoside transporter 1 (hENT1) to enter cells. High tumoral hENT1 expression has been linked with improved survival among patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1121b42cd2bc2d6e3b5f8d57ce26a2c0
https://pubmed.ncbi.nlm.nih.gov/35100740
https://pubmed.ncbi.nlm.nih.gov/35100740
Autor:
Jennifer L. Spratlin, Marco Adelmo James Iafolla, Arthur Lui, Sunita Ghosh, Michael B. Sawyer, Karen E. Mulder, A. Gallivan, Dimas Yusuf, Zainab Abdelaziz
Publikováno v:
Annals of Oncology. 28:v214-v215
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::429ecfce55bc6dddaedf59fece6e269e
https://doi.org/10.1093/annonc/mdx369.013
https://doi.org/10.1093/annonc/mdx369.013
Autor:
Jennifer L. Spratlin, Larissa J. Vos, Sunita Ghosh, Dimas Yusuf, Zainab Abdelaziz, John R. Mackey, Arthur Lui
Publikováno v:
Annals of Oncology. 29:v37
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ff5057f600aa6c5e9752c90ddf0b55e
https://doi.org/10.1093/annonc/mdy151.133
https://doi.org/10.1093/annonc/mdy151.133
Publikováno v:
Journal of Clinical Oncology. 35:e15746-e15746
e15746 Background: Pancreatic cancer (PC) continues to have poor outcomes, and biomarkers to guide individualized therapy are needed. Gemcitabine (GEM), a pyrimidine nucleoside, requires plasma membrane transporter proteins to enter cells, and defici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::755c946b6e965256a7656bc8b1760718
https://doi.org/10.1200/jco.2017.35.15_suppl.e15746
https://doi.org/10.1200/jco.2017.35.15_suppl.e15746
Autor:
Beaulieu, Carissa1 carissa.beaulieu@ahs.ca, Lui, Arthur2,3 ag_lui@yahoo.com, Yusuf, Dimas4 dimas.yusuf@alumni.ubc.ca, Abdelaziz, Zainab1,2 droncoz@live.com, Randolph, Brock5 brandolph@ualberta.ca, Batuyong, Eugene6 eugene.batuyong@ahs.ca, Ghosh, Sunita2 sunita.ghosh@ahs.ca, Bathe, Oliver F.6,7 oliver.bathe@ahs.ca, Tam, Vincent6 vincent.tam@ahs.ca, Spratlin, Jennifer L.2,8 jennifer.spratlin@ahs.ca
Publikováno v:
Current Oncology. Feb2021, Vol. 28 Issue 1, p417-427. 11p.